These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 17318199

  • 1. Immunity against breast cancer by TERT DNA vaccine primed with chemokine CCL21.
    Yamano T, Kaneda Y, Hiramatsu SH, Huang S, Tran AN, Giuliano AE, Hoon DS.
    Cancer Gene Ther; 2007 May; 14(5):451-9. PubMed ID: 17318199
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of immunity by a DNA melanoma vaccine against TRP2 with CCL21 as an adjuvant.
    Yamano T, Kaneda Y, Huang S, Hiramatsu SH, Hoon DS.
    Mol Ther; 2006 Jan; 13(1):194-202. PubMed ID: 16112911
    [Abstract] [Full Text] [Related]

  • 3. Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.
    Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL.
    Vaccine; 2004 Jul 29; 22(21-22):2894-903. PubMed ID: 15246626
    [Abstract] [Full Text] [Related]

  • 4. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.
    Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS, Vieweg J, Gilboa E.
    Nat Med; 2000 Sep 29; 6(9):1011-7. PubMed ID: 10973321
    [Abstract] [Full Text] [Related]

  • 5. Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancer.
    Kim JH, Majumder N, Lin H, Chen J, Falo LD, You Z.
    Mol Ther; 2005 Jun 29; 11(6):941-9. PubMed ID: 15922965
    [Abstract] [Full Text] [Related]

  • 6. CCL21 (SLC) improves tumor protection by a DNA vaccine in a Her2/neu mouse tumor model.
    Nguyen-Hoai T, Baldenhofer G, Sayed Ahmed MS, Pham-Duc M, Vu MD, Lipp M, Dörken B, Pezzutto A, Westermann J.
    Cancer Gene Ther; 2012 Jan 29; 19(1):69-76. PubMed ID: 21997231
    [Abstract] [Full Text] [Related]

  • 7. Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin Fc domains.
    Ferrone CR, Perales MA, Goldberg SM, Somberg CJ, Hirschhorn-Cymerman D, Gregor PD, Turk MJ, Ramirez-Montagut T, Gold JS, Houghton AN, Wolchok JD.
    Clin Cancer Res; 2006 Sep 15; 12(18):5511-9. PubMed ID: 17000687
    [Abstract] [Full Text] [Related]

  • 8. Preventive vaccination with telomerase controls tumor growth in genetically engineered and carcinogen-induced mouse models of cancer.
    Mennuni C, Ugel S, Mori F, Cipriani B, Iezzi M, Pannellini T, Lazzaro D, Ciliberto G, La Monica N, Zanovello P, Bronte V, Scarselli E.
    Cancer Res; 2008 Dec 01; 68(23):9865-74. PubMed ID: 19047167
    [Abstract] [Full Text] [Related]

  • 9. Vaccination with a DNA vaccine based on human PSCA and HSP70 adjuvant enhances the antigen-specific CD8+ T-cell response and inhibits the PSCA+ tumors growth in mice.
    Zhang X, Yu C, Zhao J, Fu L, Yi S, Liu S, Yu T, Chen W.
    J Gene Med; 2007 Aug 01; 9(8):715-26. PubMed ID: 17595048
    [Abstract] [Full Text] [Related]

  • 10. Induction of immune response and anti-tumor activities in mice with a DNA vaccine encoding human mucin 1 variable-number tandem repeats.
    Zhang S, Zhang H, Shi H, Yu X, Kong W, Li W.
    Hum Immunol; 2008 Aug 01; 69(4-5):250-8. PubMed ID: 18486759
    [Abstract] [Full Text] [Related]

  • 11. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity.
    Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW.
    Nat Biotechnol; 1999 Mar 01; 17(3):253-8. PubMed ID: 10096292
    [Abstract] [Full Text] [Related]

  • 12. Telomerase as a universal tumor antigen for cancer vaccines.
    Beatty GL, Vonderheide RH.
    Expert Rev Vaccines; 2008 Sep 01; 7(7):881-7. PubMed ID: 18767939
    [Abstract] [Full Text] [Related]

  • 13. A TLR9 agonist enhances therapeutic effects of telomerase genetic vaccine.
    Conforti A, Cipriani B, Peruzzi D, Dharmapuri S, Kandimalla ER, Agrawal S, Mori F, Ciliberto G, La Monica N, Aurisicchio L.
    Vaccine; 2010 Apr 30; 28(20):3522-30. PubMed ID: 20332048
    [Abstract] [Full Text] [Related]

  • 14. Prevention of metastases with a Mage-b DNA vaccine in a mouse breast tumor model: potential for breast cancer therapy.
    Sypniewska RK, Hoflack L, Tarango M, Gauntt S, Leal BZ, Reddick RL, Gravekamp C.
    Breast Cancer Res Treat; 2005 May 30; 91(1):19-28. PubMed ID: 15868428
    [Abstract] [Full Text] [Related]

  • 15. Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis.
    Ruffini PA, Biragyn A, Coscia M, Harvey LK, Cha SC, Bogen B, Kwak LW.
    J Leukoc Biol; 2004 Jul 30; 76(1):77-85. PubMed ID: 15075363
    [Abstract] [Full Text] [Related]

  • 16. DNA vaccines targeting tumor antigens to B7 molecules on antigen-presenting cells induce protective antitumor immunity and delay onset of HER-2/Neu-driven mammary carcinoma.
    Sloots A, Mastini C, Rohrbach F, Weth R, Curcio C, Burkhardt U, Jäger E, Forni G, Cavallo F, Wels WS.
    Clin Cancer Res; 2008 Nov 01; 14(21):6933-43. PubMed ID: 18980988
    [Abstract] [Full Text] [Related]

  • 17. Vaccination with an adenoviral vector encoding the tumor antigen directly linked to invariant chain induces potent CD4(+) T-cell-independent CD8(+) T-cell-mediated tumor control.
    Sorensen MR, Holst PJ, Pircher H, Christensen JP, Thomsen AR.
    Eur J Immunol; 2009 Oct 01; 39(10):2725-36. PubMed ID: 19637230
    [Abstract] [Full Text] [Related]

  • 18. Improved efficacy of DNA vaccination against breast cancer by boosting with the repeat beta-hCG C-terminal peptide carried by mycobacterial heat-shock protein HSP65.
    Yi H, Rong Y, Yankai Z, Wentao L, Hongxia Z, Jie W, Rongyue C, Taiming L, Jingjing L.
    Vaccine; 2006 Mar 24; 24(14):2575-84. PubMed ID: 16420967
    [Abstract] [Full Text] [Related]

  • 19. Vaccination with recombinant adenoviruses and dendritic cells expressing prostate-specific antigens is effective in eliciting CTL and suppresses tumor growth in the experimental prostate cancer.
    Kim S, Lee JB, Lee GK, Chang J.
    Prostate; 2009 Jun 15; 69(9):938-48. PubMed ID: 19267351
    [Abstract] [Full Text] [Related]

  • 20. Immunizing against breast cancer: a new swing for an old sword.
    Curigliano G, Locatelli M, Fumagalli L, Goldhirsch A.
    Breast; 2009 Oct 15; 18 Suppl 3():S51-4. PubMed ID: 19914543
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.